# The Medicines (Products for Human Use-Fees) Regulations 2008, Paragraph 7: Parallel import licence


The fee payable for an application to vary a parallel import licence shall be waived if the application is made only —
(a) because of a change to the number of an authorization granted pursuant to the provisions of the 2001 Directive by another member State for a product to which the licence relates; and
(b) so that the number of that authorization shown on the licence can be changed.

---
Source: https://www.legislation.gov.uk/uksi/2008/552/schedule/5/paragraph/7 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2008/schedule-5/paragraph-7
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.